Bioneer A/S

Where the EU money came from

Funding by EU programme. Amounts are Bioneer A/S's own share of each project, not the project's full budget.

Projects

15 EU-funded projects, newest first. Each links to the official record.

• RAMP-UPAssociated partner

  Regenerative Medicine and Advanced Medicinal Therapeutic Products United for PhD excellence

  Horizon Europe · 2026–2031 · Project on CORDIS ↗
• TOP-GUTAssociated partner

  Training for Organoids modelling Physiology and Pathology in the human gastrointestinal tract

  Horizon Europe · 2023–2027 · Project on CORDIS ↗
• ActiTOXPartner

  Active organotypic models for nanoparticle toxicological screening

  Horizon 2020 · 2019–2024 · Project on CORDIS ↗
• EBiSC2Partner

  EBiSC2 – A sustainable European Bank for induced pluripotent Stem Cells

  Horizon 2020 · 2019–2023 · Project on CORDIS ↗

  €375ktheir share
• iP-OSTEOPartner

  Induced pluripotent stem cell seeded active osteochondral nanofibrous scaffolds

  Horizon 2020 · 2019–2024 · Project on CORDIS ↗

  €9ktheir share
• circRTrainPartner

  circular RNA Biology Training Network: from biogenesis to biomarkers

  Horizon 2020 · 2017–2021 · Project on CORDIS ↗
• TAT-CFPartner

  Novel therapeutic approaches for the treatment of cystic fibrosis based on small molecule transmembrane anion transporters

  Horizon 2020 · 2016–2018 · Project on CORDIS ↗

  €557ktheir share
• eCHO SystemsPartner

  Enhancing CHO by Mammalian Systems Biotechnology (eCHO systems)

  Horizon 2020 · 2015–2018 · Project on CORDIS ↗
• EBISCPartner

  European Bank for induced pluripotent Stem Cells

  FP7 (2007 to 2013) · 2014–2017 · Project on CORDIS ↗

  €896ktheir share
• CARTARDISPartner

  Identification and validation of novel pharmaceutical drug targets for cardiovascular disease

  FP7 (2007 to 2013) · 2013–2017 · Project on CORDIS ↗

  €296ktheir share
• RNATRAINPartner

  The European non-coding RNA network

  FP7 (2007 to 2013) · 2013–2018 · Project on CORDIS ↗

  €261ktheir share
• STEMMADPartner

  Patient-specific stem cell-derived models for Alzheimer’s disease and related neurodegenerative disorders

  FP7 (2007 to 2013) · 2013–2017 · Project on CORDIS ↗

  €604ktheir share
• COMPACTPartner

  Collaboration on the Optimisation of Macromolecular Pharmaceutical Access to Cellular Targets

  FP7 (2007 to 2013) · 2012–2017 · Project on CORDIS ↗

  €488ktheir share
• BEST-STEM CELLSPartner

  Biochemically Equivalent Substitutive Technology for Stem Cells

  FP7 (2007 to 2013) · 2009–2012 · Project on CORDIS ↗

  €155ktheir share
• EURONEUT-41Partner

  EUROpean consortium on NEUTralising antibodies using gp41

  FP7 (2007 to 2013) · 2008–2014 · Project on CORDIS ↗

  €286ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

• Fraunhofer Gesellschaft zur Forderung der Angewandten Forschung eVGermany · 4 shared projects
• Kobenhavns UniversitetDenmark · 4 shared projects
• Novo Nordisk A/SDenmark · 4 shared projects
• Charite - Universitaetsmedizin BerlinGermany · 3 shared projects
• Bayer AktiengesellschaftGermany · 3 shared projects
• Eli Lilly and Company LtdUnited Kingdom · 3 shared projects
• Pfizer LimitedUnited Kingdom · 3 shared projects
• Institut National de la Sante et de la Recherche MedicaleFrance · 2 shared projects
• University College LondonUnited Kingdom · 2 shared projects
• Universiteit UtrechtNetherlands · 2 shared projects
• The University of EdinburghUnited Kingdom · 2 shared projects
• Universitair Medisch Centrum UtrechtNetherlands · 2 shared projects
• Universita Degli Studi di Roma la SapienzaItaly · 2 shared projects
• Koninklijke Nederlandse Akademie van Wetenschappen - KnawNetherlands · 2 shared projects
• Max Delbrueck Centrum Fuer Molekulare Medizin In der Helmholtz-Gemeinschaft (Mdc)Germany · 2 shared projects
• Universitatsklinikum BonnGermany · 2 shared projects

Fields it works in

Research fields recorded on its Horizon projects.

• HIV
• RNA
• alzheimer
• amyotrophic lateral sclerosis
• arteriosclerosis
• automation
• business models
• cell biology
• drug discovery
• ecosystems
• gene therapy
• genomes
• homeostasis
• inflammatory diseases